Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,500 | 560,120 | 369,005 | 153,950 | -14,618 |
| Depreciation Amortization | 164,800 | 660,067 | 491,650 | 326,418 | 163,383 |
| Income taxes - deferred | -43,800 | -208,327 | -205,972 | -141,568 | -66,385 |
| Accounts receivable | 66,000 | -21,115 | -21,979 | 277 | -8,443 |
| Accounts payable and accrued liabilities | 19,100 | -20,073 | -16,938 | -4,148 | -19,597 |
| Other Working Capital | 287,800 | -76,720 | 3,212 | 29,594 | 56,400 |
| Other Operating Activity | 28,400 | 501,956 | 378,350 | 234,058 | 156,489 |
| Operating Cash Flow | $429,800 | $1,395,908 | $997,328 | $598,581 | $267,229 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -130,100 | -460,125 | -280,125 | -505,000 | -255,000 |
| PPE Investments | -13,900 | -38,070 | -24,783 | -13,995 | -6,904 |
| Purchase Sale Intangibles | -25,000 | -10,000 | -10,000 | -10,000 | -10,000 |
| Other Investing Activity | -25,000 | -10,000 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $-169,000 | $-508,195 | $-314,908 | $-528,995 | $-271,904 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 980,767 | 980,767 | N/A | N/A |
| Debt Repayment | -757,800 | -606,000 | -598,250 | -15,500 | -7,750 |
| Common Stock Issued | 11,500 | 20,647 | 11,451 | 11,434 | 494 |
| Common Stock Repurchased | N/A | -311,429 | -311,429 | -161,428 | N/A |
| Other Financing Activity | -67,200 | -63,469 | -53,748 | -52,143 | -49,296 |
| Financing Cash Flow | $-813,500 | $20,516 | $28,791 | $-217,637 | $-56,552 |
| Exchange Rate Effect | 1,700 | -1,675 | 614 | -2,457 | -1,698 |
| Beginning Cash Position | 2,412,900 | 1,506,310 | 1,506,310 | 1,506,310 | 1,506,310 |
| End Cash Position | 1,861,900 | 2,412,864 | 2,218,135 | 1,355,802 | 1,443,385 |
| Net Cash Flow | $-551,000 | $906,554 | $711,825 | $-150,508 | $-62,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | 429,800 | 1,395,908 | 997,328 | 598,581 | 267,229 |
| Capital Expenditure | -13,900 | -38,070 | -24,783 | -13,995 | -6,904 |
| Free Cash Flow | 415,900 | 1,357,838 | 972,545 | 584,586 | 260,325 |